Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2017

Cognitive impairments, uncontrolled drinking, and neuropathological cortical changes characterize alcohol use disorder. Dysfunction of the orbitofrontal cortex (OFC), a critical cortical subregion that controls learning, decision-making, and prediction of reward outcomes, contributes to executive cognitive function deficits in alcoholic individuals. Electrophysiological and quantitative synaptomics techniques were used to test the hypothesis that heavy drinking produces neuroadaptations in the macaque OFC. Integrative bioinformatics and reverse genetic approaches were used to identify and validate synaptic proteins with novel links to heavy drinking in BXD mice. In drinking monkeys, evoked firing of OFC pyramidal neurons was reduced, whereas the amplitude and frequency of postsynaptic currents were enhanced compared with controls. Bath application of alcohol reduced evoked firing in neurons from control monkeys, but not drinking monkeys. Profiling of the OFC synaptome identified alcohol-sensitive proteins that control glutamate release (e.g., SV2A, synaptogyrin-1) and postsynaptic signaling (e.g., GluA1, PRRT2) with no changes in synaptic GABAergic proteins. Western blot analysis confirmed the increase in GluA1 expression in drinking monkeys. An exploratory analysis of the OFC synaptome found cross-species genetic links to alcohol intake in discrete proteins (e.g., C2CD2L, DIRAS2) that discriminated between low- and heavy-drinking monkeys. Validation studies revealed that BXD mouse strains with the D allele at the C2cd2l interval drank less alcohol than B allele strains. Thus, by profiling of the OFC synaptome, we identified changes in proteins controlling glutamate release and postsynaptic signaling and discovered several proteins related to heavy drinking that have potential as novel targets for treating alcohol use disorder.SIGNIFICANCE STATEMENT Clinical research identified cognitive deficits in alcoholic individuals as a risk factor for relapse, and alcoholic individuals display deficits on cognitive tasks that are dependent upon the orbitofrontal cortex (OFC). To identify neurobiological mechanisms that underpin OFC dysfunction, this study used electrophysiology and integrative synaptomics in a translational nonhuman primate model of heavy alcohol consumption. We found adaptations in synaptic proteins that control glutamatergic signaling in chronically drinking monkeys. Our functional genomic exploratory analyses identified proteins with genetic links to alcohol and cocaine intake across mice, monkeys, and humans. Future work is necessary to determine whether targeting these novel targets reduces excessive and harmful levels of alcohol drinking.

Pubmed ID: 28270566 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NIH HHS, United States
    Id: P51 OD011092
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA024426
  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA020930
  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA016662
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA023288
  • Agency: NIGMS NIH HHS, United States
    Id: P20 GM103542
  • Agency: NIAAA NIH HHS, United States
    Id: P50 AA010761
  • Agency: NIAAA NIH HHS, United States
    Id: R24 AA019431
  • Agency: NIAAA NIH HHS, United States
    Id: R37 AA009986
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR024485
  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA013499
  • Agency: NIAAA NIH HHS, United States
    Id: P60 AA010760
  • Agency: NIH HHS, United States
    Id: S10 OD010731
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA009986
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA021951

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Glutamate receptor 1 (antibody)

RRID:AB_2113602

This polyclonal targets Glutamate receptor 1

View all literature mentions

Anti-Glutamate receptor 1 (antibody)

RRID:AB_2113602

This polyclonal targets Glutamate receptor 1

View all literature mentions